Abstract
Prion diseases , traditionally referred to as TSE, are invariably fatal and highly infectious neurodegenerative diseases that affect a wide variety of mammalian species, manifesting as scrapie in sheep, BSE or ‘mad-cow’ disease in cattle, and CJD, GSS, FFI and Kulu in humans, etc. These neurodegenerative diseases are caused by the conversion from a soluble normal cellular prion protein (PrPC) into insoluble abnormally folded infectious prions (PrPSc). The hydrophobic region PrP(109–136) controls the formation into diseased prions: the normal PrP(113–120) AGAAAAGA palindrome is an inhibitor/blocker of prion diseases (Mol Cell Neurosci 15:66–78), and the highly conserved Glycine-xxx-Glycine motif PrP(119–131) can inhibit the formation of infectious prion proteins in cells (J Biol Chem 285:20213–20223). This chapter presents the studies of the 3D structures and structural dynamics of PrP(109–136).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alonso DO, DeArmond SJ, Cohen FE, Daggett V (2001) Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc Natl Acad Sci U S A 98(6):2985–2989
Apostol MI, Sawaya MR, Cascio D, Eisenberg D (2010) Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease. J Biol Chem 285(39):29671–29675
Baral PK, Swayampakula M, Rout MK, Kav NN, Spyracopoulos L, Aguzzi A, James MN (2014) Structural basis of prion inhibition by phenothiazine compounds. Structure 22(2):291–303
Barducci A, Chelli R, Procacci P, Schettino V (2005) Misfolding pathways of the prion protein probed by molecular dynamics simulations. Biophys J 88(2):1334–1343
Barducci A, Chelli R, Procacci P, Schettino V, Gervasio FL, Parrinello M (2006) Metadynamics simulation of prion protein: β-structure stability and the early stages of misfolding. J Am Chem Soc 128(8):2705–2710
Barnham KJ, Cappai R, Beyreuther K, Masters CL, Hill AF (2006) Delineating common molecular mechanisms in Alzheimer’s and prion diseases. Trends Biochem Sci 31(8):465–472
Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, Will R, Manson JC (2001) Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20(18):5070–5078
Barron RM, Thomson V, King D, Shaw J, Melton DW, Manson JC (2003) Transmission of murine scrapie to P101L transgenic mice. J Gen Virol 84(Pt 11):3165–3172
Bazan JF, Fletterick RJ, McKinley MP, Prusiner SB (1987) Predicted secondary structure and membrane topology of the scrapie prion protein. Protein Eng 1(2):125–135
Berti F, Gaggelli E, Guerrini R, Janicka A, Kozlowski H, Legowska A, Miecznikowska H, Migliorini C, Pogni R, Remelli M, Rolka K, Valensin D, Valensin G (2007) Structural and dynamic characterization of copper(II) binding of the human prion protein outside the octarepeat region. Chemistry 13(7):1991–2001
Biasini E, Tapella L, Restelli E, Pozzoli M, Massignan T, Chiesa R (2010) The hydrophobic core region governs mutant prion protein aggregation and intracellular retention. Biochem J 430(3):477–486
Biljan I, Ilc G, Giachin G, Raspadori A, Zhukov I, Plavec J, Legname G (2011) Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation. J Mol Biol 412(4):660–673
Brown DR (2000) Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Mol Cell Neurosci 15(1):66–78
Case DA, Darden TA, Cheatham TE, Simmerling III CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts BP, Wang B, Hayik S, Roitberg A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2010) AMBER 11, University of California, San Francisco
Chen PY, Lin CC, Chang YT, Lin SC, Chan SI (2002) One o-linked sugar can effect the coil-to-β structural transition of the prion peptide. Proc Natl Acad Sci U S A 99(20):12633–12638
Chen W, van der Kamp MW, Daggett V (2010) Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations. Biochem 49(45):9874–9881
Cheng HM, Tsai TWT, Huang WYC, Lee HK, Lian HY, Chou FC, Mou Y, Chu J, Chan JC (2011) Steric zipper formed by hydrophobic peptide fragment of Syrian hamster prion protein. Biochem 50(32):6815–6823
Chianini F, Fernández-Borges N, Vidal E, Gibbard L, Pintado B, de Castro J, Priola SA, Hamilton S, Eatona LS, Finlayson J, Pang Y, Steele P, Reid HW, Dagleish MP, Castilla J(2012) Rabbits are not resistant to prion infection. Proc Natl Acad Sci U S A 109(13):5080–5085
Choi JK, Park SJ, Jun YC, Oh JM, Jeong BH, Lee HP, Park SN, Carp RI, Kim YS (2006) Generation of monoclonal antibody recognized by the GxxxG motif (Glycine zipper) of prion protein. Hybridoma (Larchmt) 25(5):271–277
Chu NK, Shabbir W, Bove-Fenderson E, Araman C, Lemmens-Gruber R, Harris DA, Becker CF (2014) A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes. J Biol Chem 289(43):30144–30160
Ciccotosto GD, Cappai R, White AR (2008) Neurotoxicity of prion peptides on cultured cerebellar neurons. In: Hill AF (ed) Prion protein protocols methods. Methods in molecular biology, vol 459. Humana Press, Totowa, pp 83–96 (chapter 6)
Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF (2014) Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease sensitive prion species with increased lethality. J Virol 88(5):2690–2703
Cui T, Daniels M, Wong BS, Li R, Sy MS, Sassoon J, Brown DR (2003) Mapping the functional domain of the prion protein. Eur J Biochem 270(16):3368–3376
Daidone I, Nola AD, Smith JC (2011) Molecular origin of Gerstmann-Straussler-Scheinker syndrome: insight from computer simulation of an amyloidogenic prion peptide. Biophys J 100(12):3000–3007
Daskalov A, Gantner M, Wälti MA, Schmidlin T, Chi CN, Wasmer C, Schütz A, Ceschin J, Clavé C, Cescau S, Meier B, Riek R, Saupe SJ (2014) Contribution of specific residues of the β-solenoid fold to HET-s prion function, amyloid structure and stability. PLoS Pathog 10(6):e1004158
Daude N, Ng V, Watts JC, Genovesi S, Glaves JP, Wohlgemuth S, Schmitt-Ulms G, Young H, McLaurin J, Fraser PE, Westaway D (2010) Wild-type Shadoo proteins convert to amyloid-like forms under native conditions. J Neurochem 113(1):92–104
De Fea KA, Nakahara DH, Calayag MC, Yost CS, Mirels LF, Prusiner SB, Lingappa VR (1994) Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. J Biol Chem 269(24):16810–16820
De Marco ML, Daggett V (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A 101(8):2293–2298
De Simone A, Dodson GG, Verma CS, Zagari A, Fraternali F (2005) Prion and water; tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci U S A 102(21):7535–7540
Dragani B, Cocco R, Principe DR, Paludi D, Aceto A (2001) Conformational properties of five peptides corresponding to the entire sequence of glutathione transferase domain II. Arch Biochem Biophys 389(1):15–21
Fei L, Perrett S (2009) Disulfide bond formation significantly accelerates the assembly of Ure2p fibrils because of the proximity of a potential amyloid stretch. J Biol Chem 284(17):11134–11141
Fernandez-Borges N, Chianini F, Erana H, Vidal E, Eaton SL, Pintado B, Finlayson J, Dagleish MP, Castilla J (2012) Naturally prion resistant mammals: a utopia? Prion 6(5):425–429
Gaggelli E, Bernardi F, Molteni E, Pogni R, Valensin D, Valensin G, Remelli M, Luczkowski M, Kozlowski H (2005) Interaction of the human prion PrP (106–126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies. J Am Chem Soc 127(3):996–1006
Garnier J, Osguthorpe DJ, Robson B (1978) Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120(1):97–120
Glockshuber R, Hornemann S, Billeter M, Riek R, Wider G, Wuthrich K (1998) Prion protein structural features indicate possible relations to signal peptidases. FEBS Lett 426(3):291–296
Govaerts C, Wille H, Prusiner SB, Cohen EE (2004) Evidence for assembly of prions with left-handed β-helices into trimers. Proc Natl Acad Sci U S A 101(22):8342–8347
Haire LF, Whyte SM, Vasisht N, Gill AC, Verma C, Dodson EJ, Dodson GG, Bayley PM (2004) The crystal structure of the globular domain of sheep prion protein. J Mol Biol 336(5):1175–1183
Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32(4):1009–1016
Harrison CF, Barnham KJ, Hill AF (2007) Neurotoxic species in prion disease: a role for PrP isoforms? J Neurochem 103(5):1709–1720
Harrison CF, Lawson VA, Coleman BM, Kim YS, Masters CL, Cappai R, Barnham KJ, Hill AF (2010) Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity. J Biol Chem 285(26):20213–20223
Hasnain SS, Murphy LM, Strange RW, Grossmann JG, Clarke AR, Jackson GS, Collinge J (2001) XAFS study of the high-affinity copper-binding site of HuPrP(91–231) and its low-resolution structure in solution. J Mol Biol 311(3):467–473
Holscher C, Bach UC, Dobberstein B (2001) Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J Biol Chem 276(16):13388–13394
Holscher C, Delius H, Burkle A (1998) Overexpression of nonconvertible PrPC delta114–121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrPSc accumulation. J Virol 72(2):1153–1159
Huang D, Caflisch A (2015) Evolutionary conserved Tyr169 stabilizes the β2-α2 loop of prion protein. J Am Chem Soc 137(8):2948–2957
Ilc G, Giachin G, Jaremko M, Jaremko L, Benetti F, Plavec J, Zhukov I, Legname G (2010) NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS ONE 5(7):e11715
Inouye H, Kirschner DA (1996) Refined fibril structures: the hydrophobic core in Alzheimer’s amyloid β-protein and prion as revealed by X-ray diffraction. Ciba Found Symp 199:22–35, (chapter 3); discussion 35–39
James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, Cohen FE (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A 94(19):10086–10091
Jeong BH, Jin HT, Choi EK, Carp RI, Kim YS (2012) Lack of association between 14-3-3 β gene (YWHAB) polymorphisms and sporadic Creutzfeldt-Jakob disease (CJD). Mol Biol Rep 39(12):10647–10653
Jones CE, Klewpatinond M, Abdelraheim SR, Brown DR, Viles JH (2005) Probing copper2+ binding to the prion protein using diamagnetic nickel2+ and 1H NMR: the unstructured N terminus facilitates the coordination of six copper2+ ions at physiological concentrations. J Mol Biol 346(5):1393–1407
Joszai V, Turi I, Kallay C, Pappalardo G, Di Natale G, Rizzarelli E, Sovago I (2012) Mixed metal copper(II)-nickel(II) and copper(II)-zinc(II) complexes of multihistidine peptide fragments of human prion protein. J Inorg Biochem 112:17–24. doi:10.1016/j.jinorgbio.2012.02.014
Julien O, Chatterjee S, Bjorndahl TC, Sweeting B, Acharya S, Semenchenko V, Chakrabartty A, Pai EF, Wishart DS, Sykes BD, Cashman NR (2011) Relative and regional stabilities of the hamster, mouse, rabbit, and bovine prion proteins toward urea unfolding assessed by nuclear magnetic resonance and circular dichroism spectroscopies. Biochemistry 50(35):7536–7545
Julien O, Chatterjee S, Thiessen A, Graether SP, Sykes BD (2009) Differential stability of the bovine prion protein upon urea unfolding. Protein Sci 18(10):2172–2182
Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577–2637
Kanyo ZF, Pan KM, Williamson RA, Burton DR, Prusiner SB, Fletterick RJ, Cohen FE (1999) Antibody binding defines a structure for an epitope that participates in the PrPC to PrPSc conformational change. J Mol Biol 293(4):855–863
Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR, Pai EF, Chakrabartty A (2010) Prion disease susceptibility is affected by β-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci U S A 107(46):19808–19813
Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA (2012) The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. J Biol Chem 287(43):36465–36472
Klewpatinond M, Viles JH (2007) Fragment length influences affinity for Cu2+ and Ni2+ binding to His96 or His111 of the prion protein and spectroscopic evidence for a multiple histidine binding only at low pH. Biochem J 404(3):393–402
Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8(9):770–774
Knolmurodov K, Hirano Y, Ebisuzaki T (2003) MD simulations on the influence of disease-related amino acid mutations in the human prion protein. Chem-Bio Inf J 3(2):86–95
Kourie JI, Kenna BL, Tew D, Jobling MF, Curtain CC, Masters CL, Barnham KJ, Cappai R (2003) Copper modulation of ion channels of PrP[106–126] mutant prion peptide fragments. J Membr Biol 193(1):35–45
Kuwata K, Matumoto T, Cheng H, Nagayama K, James TL, Roder H (2003) NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106–126. Proc Natl Acad Sci U S A 100(25):14790–14795
Kuznetsov IB, Rackovsky S (2004) Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations. Protein Sci 13(12):3230–3244
Lange A, Gattin Z, Van Melckebeke H, Wasmer C, Soragni A, van Gunsteren WF, Meier BH (2009) A combined solid-state NMR and MD characterization of the stability and dynamics of the HET-s(218–289) prion in its amyloid conformation. Chembiochem 10(10):1657–1665
Lau A, Mays CE, Genovesi S, Westaway D (2012) RGG repeats of PrP-like Shadoo protein bind nucleic acids. Biochemistry 51(45):9029–9031
Laws DD, Bitter HM, Liu K, Ball HL, Kaneko K, Wille H, Cohen FE, Prusiner SB, Pines A, Wemmer DE (2001) Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc Natl Acad Sci U S A 98(20):11686–11690
Lee SW, Mou Y, Lin SY, Chou FC, Tseng WH, Chen C, Lu CYD, Yu SSF, Chan JCC (2008) Steric zipper of the amyloid fibrils formed by residues 109 to 122 of the Syrian hamster prion protein. J Mol Biol 378(5):1142–1154
Lee DC, Sakudo A, Kim CK, Nishimura T, Saeki K, Matsumoto Y, Yokoyama T, Chen SG, Itohara S, Onodera T (2006) Fusion of Doppel to octapeptide repeat and N-terminal half of hydrophobic region of prion protein confers resistance to serum deprivation. Microbiol Immunol 50(3):203–209
Li J, Mei FH, Xiao GF, Guo CY, Lin DH (2007) 1H, 13C and 15N resonance assignments of rabbit prion protein 91–228. J Biomol NMR 38(2):181
Liang J, Kong Q (2012) α-Cleavage of cellular prion protein. Prion 6(5):453–460
Liao YC, Tokes Z, Lim E, Lackey A, Woo CH, Button JD, Clawson GA (1987) Cloning of rat “prion-related protein” cDNA. Lab Invest 57(4):370–374
Lin DH, Wen Y (2011) Progresses on prion proteins. Scientia Sinica Chimica 41(4):683–698 (in Chinese)
Liu H, Farr-Jones S, Ulyanov NB, Llinas M, Marqusee S, Groth D, Cohen FE, Prusiner SB, James TL (1999) Solution structure of Syrian hamster prion protein rPrP(90–231). Biochemistry 38(17):5362–5377
Lutz J, Brabeck C, Niemann HH, Kloz U, Korth C, Lingappa VR, Bürkle A (2010) Microdeletions within the hydrophobic core region of cellular prion protein alter its topology and metabolism. Biochem Biophys Res Commun 393(3):439–444
Ma BY, Nussinov R (2002) Molecular dynamics simulations of alanine rich β-sheet oligomers: insight into amyloid formation. Protein Sci 11(10):2335–2350
Margittai M, Langen R (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q Rev Biophys 41(3–4):265–297
Mastrianni JA, Curtis MT, Oberholtzer JC, Da Costa MM, DeArmond S, Prusiner SB, Garbern JY (1995) Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology 45(11):2042–2050
Mays CE, Coomaraswamy J, Watts JC, Yang J, Ko KW, Strome B, Mercer RC, Wohlgemuth SL, Schmitt-Ulms G, Westaway D (2014) Endoproteolytic processing of the mammalian prion glycoprotein family. FEBS J 281(3):862–876
Moore RA, Vorberg I, Priola SA (2005) Species barriers in prion diseases – brief review. Arch Virol Suppl 19:187–202
Muramoto T, Kitamoto T, Tateishi J, Goto I (1992) Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Brain Res 599(2):309–316
Ning L, Wang Q, Zheng Y, Liu H, Yao X (2015) Effects of the A117V mutation on the folding and aggregation of palindromic sequences (PrP113–120) in prion: insights from replica exchange molecular dynamics simulations. Mol Biosyst 11(2):647–655
Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, Hill AF (2010) Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol 84(13):6678–6686
Oliveira-Martins JB, Yusa S, Calella AM, Bridel C, Baumann F, Dametto P, Aguzzi A (2010) Unexpected tolerance of α-cleavage of the prion protein to sequence variations. PLoS ONE 5(2):e9107
Ott CM, Akhavan A, Lingappa VR (2007) Specific features of the prion protein transmembrane domain regulate nascent chain orientation. J Biol Chem 282(15):11163–11171
Ott CM, Lingappa VR (2004) Signal sequences influence membrane integration of the prion protein. Biochemistry 43(38):11973–11982
Owen JP, Maddison BC, Whitelam GC, Gough KC (2007) Use of thermolysin in the diagnosis of prion diseases. Mol Biotechnol 35(2):161–170
Patel A, Vasiljevic S, Jones IM (2013) Unique structural properties associated with mouse prion triangle 105–125 protein. Prion 7(3):235–243
Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412(6848):739–743
Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FE, Prusiner SB, Burton DR (1997) A conformational transition at the N-terminus of the prion protein features in formation of the scrape isoform. J Mol Biol 273(3):614–622
Pimenta J, Viegas A, Sardinha J, Martins IC, Cabrita EJ, Fontes CM, Prates JA, Pereira RM (2013) NMR solution structure and SRP54M predicted interaction of the N-terminal sequence (1–30) of the ovine Doppel protein. Peptides 49C:32–40. doi:10.1016/j.peptides.2013.08.013
Polymenidoua M, Trusheimb H, Stallmacha L, Moosa R, Julius JA, Mielea G, Lenzbauerb C, Aguzzia A (2008) Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine 26(21):2601–2614
Premzl M, Sangiorgio L, Strumbo B, Marshall Graves JA, Simonic T, Gready JE (2003) Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene 314:89–102
Priola SA, Chesebro B (1995) A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 69(12):7754–7758
Ragg E, Tagliavini F, Malesani P, Monticelli L, Bugiani O, Forloni G, Salmona M (1999) Determination of solution conformations of PrP106–126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics. Eur J Biochem 266(3):1192–1201
Rivillas-Acevedo L, Grande-Aztatzi R, Lomeli I, Garcia JE, Barrios E, Teloxa S, Vela A, Quintanar L (2011) Spectroscopic and electronic structure studies of copper(II) binding to His111 in the human prion protein fragment 106–115: evaluating the role of protons and Methionine residues. Inorg Chem 50(5):1956–1972
Saez-Cirion A, Nieva JL, Gallaher WR (2003) The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide. AIDS Res Hum Retroviruses 19(11):969–978
Sakudo A, Lee DC, Li S, Nakamura T, Matsumoto Y, Saeki K, Itohara S, Ikuta K, Onodera T (2005) PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line. Biochem Biophys Res Commun 328(1):14–19
Sakudo A, Lee DC, Nishimura T, Li S, Tsuji S, Nakamura T, Matsumoto Y, Saeki K, Itohara S, Ikuta K, Onodera T (2005) Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem Biophys Res Commun 326(3):600–606
Sakudo A, Nakamura I, Lee DC, Saeki K, Ikuta K, Onodera T (2007) Neurotoxic prion protein (PrP) fragment 106–126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line. Protein Pept Lett 14(1):1–6
Saupe SJ (2011) The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Semin Cell Dev Biol 22(5):460–468
Sauve S, Buijs D, Gingras G, Aubin Y (2012) Interactions between the conserved hydrophobic region of the prion protein and dodecylphosphocholine micelles. J Biol Chem 287(3):1915–1922
Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJ, McFarlane HT, Madsen A, Riekel C, Eisenberg D (2007) Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447(7143):453–457
Seabury CM, Derr JN (2003) Identification of a novel ovine PrP polymorphism and scrapie-resistant genotypes for St. Croix White and a related composite breed. Cytogenet Genome Res 102(1–4):85–88
Shi Q, Dong XP (2011) (Ctm)PrP and ER stress: a neurotoxic mechanism of some special PrP mutants. Prion 5(3):123–125
Smith CJ, Drake AF, Banfield BA, Bloomberg GB, Palmer MS, Clarke AR, Collinge J (1997) Conformational properties of the prion octa-repeat and hydrophobic sequences. FEBS Lett 405(3):378–384
Stewart P, Shen C, Zhao D, Goldmann W (2009) Genetic analysis of the SPRN gene in ruminants reveals polymorphisms in the alanine-rich segment of shadoo protein. J Gen Virol 90(Pt 10):2575–2580
Supattapone S, Muramoto T, Legname G, Mehlhorn I, Cohen FE, DeArmond SJ, Prusiner SB, Scott MR (2001) Identification of two prion protein regions that modify scrapie incubation time. J Virol 75(3):1408–1413
Suzuki T, Kurokawa T, Hashimoto H, Sugiyama M (2002) cDNA sequence and tissue expression of Fugu rubripes prion protein-like: a candidate for the teleost orthologue of tetrapod PrPs. Biochem Biophys Res Commun 294(4):912–917
Tcherkasskaya O, Sanders W, Chynwat V, Davidson EA, Orser CS (2003) The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides. J Biomol Struct Dyn 21(3):353–365
Tseng CY, Yu CP, Lee HC (2009) Integrity of H1 helix in prion protein revealed by molecular dynamic simulations to be especially vulnerable to changes in the relative orientation of H1 and its S1 flank. Eur Biophys J 38(5):601–611
Turi I, Kallay C, Szikszai D, Pappalardo G, Di Natale G, De Bona P, Rizzarelli E, Sovago I (2010) Nickel(II) complexes of the multihistidine peptide fragments of human prion protein. J Inorg Biochem 104(8):885–891
Valensin D, Gajda K, Gralka E, Valensin G, Kamysz W, Kozlowski H (2010) Copper binding to chicken and human prion protein amylodogenic regions: differences and similarities revealed by Ni2+ as a diamagnetic probe. J Inorg Biochem 104(1):71–78
Vilches S, Vergara C, Nicolas O, Sanclimens G, Merino S, Varon S, Acosta GA, Albericio F, Royo M, Del Rio JA, Gavin R (2013) Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein. PLoS ONE 8(8):e70881
Viles JH, Donne D, Kroon G, Prusiner SB, Cohen FE, Dyson HJ, Wright PE (2001) Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics. Biochemistry 40(9):2743–2753
Vorberg I, Martin HG, Eberhard P, Suzette AP (2003) Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 77(3):2003–2009
Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306(5702):1793–1796
Wang X, He L, Zhao C, Du W, Lin J (2013) Gold complexes inhibit the aggregation of prion neuropeptides. J Biol Inorg Chem 18(7):767–778
Wang F, Yin S, Wang X, Zha L, Sy MS, Ma J (2010) Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 49(37):8169–8176
Wegner C, Romer A, Schmalzbauer R, Lorenz H, Windl O, Kretzschmar HA (2002) Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells. J Gen Virol 83(Pt 5):1237–1245
Wen Y, Li J, Xiong MQ, Peng Y, Yao WM, Hong J, Lin DH (2010) Solution structure and dynamics of the I214V mutant of the rabbit prion protein. PLoS ONE 5(10):e13273
Wen Y, Li J, Yao WM, Xiong MQ, Hong J, Peng Y, Xiao GF, Lin DH (2010) Unique structural characteristics of the rabbit prion protein. J Biol Chem 285(41):31682–31693
Xu H, He X, Zheng H, Huang LJ, Hou F, Yu Z, de la Cruz MJ, Borkowski B, Zhang X, Chen ZJ, Jiang QX (2014) Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife 3:e01489
Yuan FF, Biffin S, Brazier MW, Suzrez M, Cappai R, Hill AF, Collins SJ, Sullivan JS, Middleton D, Multhaup G, Geczy AF, Masters CL (2005) Detection of prion epitopes on PrPC and PrPSc of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP. Immunol Cell Biol 83(6):632–637
Zhang ZQ, Chen H, Lai LH (2007) Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinf 23(17):2218–2225
Zhang X, Zhou X, Ding T, Gan W, Yang L, Yin X, Zhao D (2012) Polymorphisms of SPRN (shadow of prion protein homology) in three breeds of sheep in China. Virus Genes 44(3):548–550
Zhao H, Liu LL, Du SH, Wang SQ, Zhang YP (2012) Comparative analysis of the Shadoo gene between cattle and buffalo reveals significant differences. PLoS ONE 7(10):e46601
Zweckstetter M (2013) Conserved amyloid core structure of stop mutants of the human prion protein. Prion 7(3):193–197
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Zhang, J. (2015). The Hydrophobic Region PrP(109–136). In: Molecular Structures and Structural Dynamics of Prion Proteins and Prions. Focus on Structural Biology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7318-8_10
Download citation
DOI: https://doi.org/10.1007/978-94-017-7318-8_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7317-1
Online ISBN: 978-94-017-7318-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)